Trial NHL-ZNS-Rezidiv

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

NHL-ZNS-Rezidiv

Full title

Kombinierte Systemische und intrathekale Chemotherapie mit nachfolgender Hochdosischemothrapie und autologer Stammzelltransplanatation bei ZNS-Rezidiven aggressiver Lymphome

EudraCT number

2006-006516-30

Responsible organization

Medizinische Klinik III, Telefon: 089440072551

Indications

Classification	Code	Description
-		CNS Tumors

Trial design

Trial type

Interventional

Blinding type

Open

Phase

Status

Trial finished

Votes

Institutional review board - vote

Unknown

Initiiation & lock

Date of lock (planned / actual)

2012-01-02 / Unknown

Therapy

Therapy line

Participants

	Function	Prename	Surname	Organization
	Principal Investigator	MARTIN	DREYLING	Keine Organisationseinheit angegeben